MimiX biotherapeutics introduces Sound Induced Morphogenesis. We extend the boundaries of biofabrication, making bioengineered, artificial human organs and tissues a future reality.
Sound Induced Morphogenesis (SIM) is a revolutionary approach in biofabrication. It mirrors nature’s design, to aggregate and pattern biologicals by tuning sound profiles under contactless, fast and delicate culture conditions resulting in a morphologically induced tissue generation.
We introduce cymatiX®, a unique acoustic biofabrication solution that makes the Sound Induced Morphogenesis technology easily accessible to the scientific and clinical community
Visit www.mimixbio.com to learn more. mimiX biotherapeutics is a Swiss biomedical company.
Company Details
- Employees
- 6
- Founded
- -
- Address
- Aarbergstrasse 46, Sipbb,switzerland
- in****@****bio.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- mimixbio.com
- Keywords
- Sound Induced Morphogenesis, Bioprinting, Regenerative Medicine, Tissue Engineering, Additive Manufacturing, biofabrication, cellular agriculture, Tissue engineering.
- HQ
- Biel, Berne
Mimix Biotherapeutics Questions
Mimix Biotherapeutics's website is mimixbio.com
Mimix Biotherapeutics's LinkedIn profile is https://ch.linkedin.com/company/mimixbiotherapeutics
Mimix Biotherapeutics has
6 employees.
View email and phone details for 6
employees at Mimix Biotherapeutics.
Mimix Biotherapeutics's industry is
Biotechnology Research
Mimix Biotherapeutics's top competitors are
Cellestia Biotech,
Regenhu,
Eors - European Orthopaedic Research Society,
Amphilix Ag,
Ao Foundation,
Ao Research Institute Davos (Ari),
Ao Trauma,
Tissuelabs,
Herosupport Sa,
Nagi Bioscience.
Mimix Biotherapeutics's support email address is info@mimixbio.com
Mimix Biotherapeutics's categories are Biotechnology Research
Mimix Biotherapeutics's founding year is 2019
